Prevention and Treatment of School Myopia
Article information
J Korean Med Assoc. 2007;50(3):259-264
Publication date (electronic) : 2007 March 31
doi :
https://doi.org/10.5124/jkma.2007.50.3.259
Abstract
Myopia is the most common refractive error throughout the world. Exact and relative etiologies of myopia have not been investigated in detail, although the high prevalence rate of myopia in school children has been well documented. Patients with myopia must endure the physical and financial burden of spectacles or contact lenses throughout their lives. The National Eye Institute estimated that the costs of refractive eye examinations amount to $1 billion annually, with another $1.5 billion spent on eyeglasses each year. The age of onset of myopia is frequently between 5 to 15 years. There has been a dramatic increase in the prevalence rates of myopia over the past decades in Korea and other parts of Asia. The prevalence rate was 8~15% in 1970s, 23% in 1980s, 38% in 1990s, and 46.2% in 2000s in Korean school children. The remarkable increase in Asian school children suggests that life style risk factors during the school periods may have a great impact on the development of school myopia and the overall population prevalence rate of myopia. Because the gene pool has not changed significantly over the past decades, the rapid increase of the prevalence rates of myopia has been attributed to increases in near-work activities and environmental factors. Atropine is effective in preventing myopia by a non-accommodative mechanism. Atropine is a broad-band muscarinic antagonist that binds to all five identified muscarinic receptors. Animal and clinical studies have shown that the M1-selective muscarinic antagonist, pirenzepine, is effective in reducing axial length enlargement and preventing myopia.
Keywords: Prevalence rate; Atropine; Pirezepine; Myopia
References
1. Tano Y. Pathologic myopia: Where are we now. Am J Ophthalmol 2002. 134645–660.
2. National Advisory Eye Council. Strabismus and Amblyopia Panel. Vision Research: A National Plan;1983-1987 1987. Washington DC: National Institutes of Health;
3. Lin LL, Shih YF, Tsai CB, Chen CJ, Lee LA, Hung PT, Hou PK. Epidemiologic study of ocular refraction among schoolchildren in Taiwan. Optom Vis Sci 1999. 76275–281.
4. Lin Lk, Chen CJ, Hung PT, Ko LS. National-wide survey of myopia among schoolchildren in Taiwan. Acta Ophthalmol 1988. 185S. 29–33.
5. Saw SM, Katz J, Schein OD, Chew SJ, Chan TK. Epidemiology of myopia. Epidemiol Rev 1996. 18175–187.
6. Saw SM, Tong L, Chua WH, Chia KS, Koh D, Tan DT, Katz J. Incidence and progression of myopia in Singaporean school children. Invest ophthalmol Vis Sci 2005. 4651–57.
7. Saw SM, Hong RZ, Zhang MZ, Fu ZF, Ye M, Tan D, Chew SJ. Near-work activity and myopia in rural and urban schoolchildren in China. J Pediatr Ophthalmol Strabismus 2001. 38149–155.
8. Tan NW, Saw SM, Lam DS, Cheng HM, Rajan U, Chew SJ. Temporal variations in myopia progression in Singaporean children within an academic year. Optom Vis Sci 2000. 77465–472.
9. Kim SH, Kim SM. Survey on causative factors responsible for the school myopia. J Korean Ophthalmol Soc 1977. 1845–49.
10. Ji NC, Yoon WJ, Lee JS. A survey of the refractive state of elementary school children in rural area. J Korean Ophthalmol Soc 1997. 38458–465.
11. Hong JS, Koo KL, Lee HY. Survey on the refractive status of primary school children with subnormal visual acuity. J Korean Ophthalmol Soc 1999. 403168–3173.
12. Kang JE, Jun RM, Lee HJ, et al. Distribution of refractive errors and quantified optometric values in urban elementary fourth graders in Korea. J Korean Ophthalmol Soc 2004. 451141–1149.
13. Kirby AW, Sutton L, Weiss H. Elongation of cat eyes following neonatal lid sutures. Invest Ophthalmol Vis Sci 1982. 22274–277.
14. Rabin J, Van Sluyters RC, Malach R. Emmetropization: A vision-dependent phenomenon. Invest Ophthalmol Vis Sci 1981. 20561–564.
15. Gross DA, Criswell MH. Myopia development in experimental animal. Am J Optom Physiol Optics 1983. 60250–268.
16. Christensen AM, Wallmann J. Evidence that increased scleral growth underlies visual deprivation myopia in chicks. Invest Ophthalmol Vis Sci 1991. 322143–2150.
17. Hoyt CS, Stone RD, Fromer C, Billdon FA. Monocular axial myopia associated with neonatal eyelid closure in human infants. Am J Ophthalmol 1981. 91197–200.
18. Raviola E, Weisel TN. An animal model of myopia. N Engl J Med 1985. 3121615.
19. Brecha N, Karten HJ, Laverack C. Enkephalin-containing amacrine cells in the avian retina: immunohistochemical localization. Proc Natl Acad Sci 1979. 763010–3014.
20. Karten HJ, Brecha N. Localization of substance-p immunoactivity in amacrine cells of the retina. Nature 1980. 28387–88.
21. Iuvone PM, Galli CL, Garrison-Gund CK, Neff NH. Light stimulates tyrosine hydroxylase activity and dopamine synthesis in retinal amacrine neurons. Science 1978. 202901–902.
22. Min BM, Lee CH, Lee YH, et al. The effect of Bromocriptine on the inhibition of eyeball growth at various concentration in myopic chicken model. J Korean Ophthalmol Soc 1996. 372104–2110.
23. Kim JC, Koo BS. A study of prevailing features and causes of myopia and visual impairment in urban school children. J Korean Ophthalmol Soc 1988. 29165–181.
24. Kang SH, Kim PS, Choi DG. Prevalence of myopia in 19-year-old Korean males: The relationship between the prevalence and education or urbanization. J Korean Ophthalmol Soc 2004. 452082–2087.
25. Sorsby A. Refraction. Ophthalmic genetics 1970. 2nd edth ed. London: Butterworths; 38–51.
26. Zadnik K, Satariano WA, Mutti DO, shdtz RI, Adams AJ. The effect of parental history of myopia on children\'s eye size. JAMA 1994. 2711323–1327.
27. Pacella R, McLellan J, Grice K, Del Bono EA, Wiggs JL, Gwiazda JE. Role of genetic factors in the etiology of juvenilenset myopia based on a longitudinal study of refractive error. Optom Vis Sci 1999. 76381–386.
28. Edward MH. Effect of parental myopia on the development of myopia in Hong Kong Chineses. Ophthalmic Physiol Optics 1998. 18477–483.
29. Sorsby A, Sheridan M, Leary GA. Refraction and its components in twins 1962. London: Med Res Counc Spec Tep Ser;
30. Chen CJ, Cohen BH, Diamond EL. Genetic and environmental effects on the development of myopia in Chinese twin children. Ophthalmic Pediatr Genet 1985. 6113–119.
31. Wong L, Coggon D, Cruddas M, Hwang CH. Education, reading, and familial tendency as risk factors for myopia in Hong Kong fishermen. J Epidemiol Community Health 1993. 4750–53.
32. Kelly TS. Myopia or expansion glaucoma. Doc Ophthalmol Proc Series 1981. 28109–116.
33. Coleman DJ. Unified model for accommodative mechanism. Am J Ophthalmol 1970. 691063–1079.
34. Young F. The development and control of myopia in human and subhuman primates. Contacto 1975. 1916–31.
35. Abraham SV. Control of myopia with tropicamide. J Pediatr Ophthalmol 1967. 410–22.
36. Green PR. Mechanical consideration in myopia: relative effects of accommodation, convergence, intraocular pressure, and extraocular muscle. Am J Optom Physiol Optics 1980. 57902–914.
37. Blegvad O. Om myopiens progression. Ugeskr Laeger 1918. 80287–298.
38. Rogenberg T, Goldschmidt E. The onset and progression of myopia in Danish school children. Doc Ophthalmol 1981. 2833–39.
39. Mäntyjärvi MI. Predicting of myopia progression in school children. J Pediatr Ophthalmol Strabismus 1985. 2271–75.
40. Kim SY, Min BM. Myopic progression according to the age of onset in childhoods. J Korean Ophthalmol Soc 1998. 39721–727.
41. Bedrossian RH. The effect of atropine on myopia. Ann Ophthalmol 1971. 3891–891.
42. Kennedy RH. Progression of myopia. Trans Am Ophthalmol Soc 1995. 93755–800.
43. McBrien NA, Moghaddam HO, Reeder AP. Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism. Invest Ophthalmol Vis Sci 1993. 34205–215.
44. Wang IJ, ShihYF , Tseng HS, Huang SH, Lin LL, Hung PT. The effect of intravitreal injection of atropine on the proliferation of scleral chondrocyte in vivo. J Ocul Pharmacol Ther 1998. 14337–343.
45. Lind GJ, Chew SJ, Marzani D, Wallman J. Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes. Invest Ophthalmol Sci Vis 1998. 392217–2231.
46. Choi TH, Jeong JW, Choi YY. The effect of atropine on myopic progression in children. J Korean Ophthalmol Soc 2005. 461189–1195.
47. Siatkowski RM, Cotter S, Miller JM, Scher CA, Crockett RS, Novack GD. US Pirenzepine Study Group. Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia. Arch Ophthalmol 2004. 1221667–1674.
Article information Continued
Copyright © 2007 Korean Medical Association